|
| Experience of Director MA Lian-zhen in the treatment of coronary heart disease by Dingtong Jiuxin capsules |
| Hits 1743 Download times 2089 Received:October 12, 2015 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2016.02.01 |
| Key Words
MA Lian-zhen;thoracic obstruction;angina pectoris of coronary heart disease |
| Author Name | Affiliation | | JIA Jun-bing | Department of Cardiology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China | | FAN Rui-hong | Department of Cardiology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China |
|
| Abstract
|
| Coronary heart disease is a common disease of cardiovascular system. MA Lian-zhen director, after more than 40 years of research, believed that Yang deficiency cold coagulation, blood stasis resistance was a common syndrome type, and developed the Dingtong Jiuxin capsules which had the effect of anti atherosclerosis, anti-platelet aggregation, lowering blood lipids, improving blood rheology, inhibiting the release of inflammatory cytokines, to provide the scientific basis for the treatment of coronary heart disease, and it was worthy of clinical promotion. |
|
|
|
|
|
|
|
